Candida peritonitis in dogs: report of 5 cases.

Candida peritonitis is reported in people and is associated with significant morbidity and mortality compared with sterile or bacterial peritonitis. Recognized predisposing risk factors include peritoneal dialysis, hollow viscous organ perforation, abdominal surgery, inflamed intestinal mucosa, antimicrobial administration, and immunosuppression. In this report, we describe 5 cases of dogs with peritonitis complicated by Candida spp; 3 dogs with C albicans, one dog with C albicans and C glabrata, and one dog with C glabrata only. The 3 dogs with C albicans peritonitis presented with duodenal perforation due to NSAID therapy, intestinal resection and anastomosis following postspay-surgery dehiscence, and intestinal foreign body removal. The 2 dogs with C glabrata peritonitis had undergone cholecystectomy due to gall bladder rupture and dehiscence of intestinal biopsy removal sites following exploratory laparatomy. In all cases, initial diagnosis of fungal peritonitis was made via cytologic examination of peritoneal effusions, which revealed marked pyogranulomatous inflammation with numerous 3-8 μm oval, deeply basophilic yeast organisms with thin clear capsules noted within phagocytes and extracellularly. In addition, germ tube formation, hyphae, and pseudohyphae were rarely seen in some of the cases with pure C albicans. Identity of the organisms was determined by culture in all cases and confirmed by PCR in 3 cases. Candida spp. are commensals normally inhabiting the alimentary, the upper respiratory, and the lower urogenital tracts of mammals. They are opportunistic pathogens that can invade and colonize tissue when a patient is immune-compromised or there is disruption of the mucosal barrier. Candida peritonitis should be considered in patients with peritoneal contamination with gastrointestinal or biliary contents.

[1]  J. Mantz,et al.  Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. , 2002, Archives of surgery.

[2]  O. Lortholary,et al.  A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  K. Giercksky,et al.  Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. , 2002, Critical care medicine.

[4]  R. Cirocchi,et al.  The sigmoid volvulus: surgical timing and mortality for different clinical types , 2010, World journal of emergency surgery : WJES.

[5]  David W. Johnson,et al.  Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. , 2009, Kidney international.

[6]  M. Sartelli A focus on intra-abdominal infections , 2010, World journal of emergency surgery : WJES.

[7]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[8]  J. Mantz,et al.  Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?* , 2003, Critical care medicine.

[9]  Chih-Wei Yang,et al.  Candida Cholecystitis in a Diabetic Patient on Chronic Peritoneal Dialysis , 2008 .

[10]  J. Matuszkiewicz-Rowińska Update on Fungal Peritonitis and its Treatment , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  U. Sonnenborn,et al.  Yeasts in the gut: from commensals to infectious agents. , 2009, Deutsches Arzteblatt international.

[12]  L. Loh,et al.  Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with Peptide-Pulsed Blood , 2008, PLoS pathogens.

[13]  M. Falagas,et al.  Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  S. Poutanen,et al.  Identification of a new species, Candida subhashii, as a cause of peritonitis. , 2009, Medical mycology.

[15]  A. Raisis,et al.  Candida albicans peritonitis in a dog. , 2010, Journal of veterinary emergency and critical care.

[16]  Russell E. Lewis,et al.  Overview of the changing epidemiology of candidemia. , 2009, Current medical research and opinion.

[17]  N. Gow,et al.  Pseudohypha budding patterns of Candida albicans. , 2009, Medical mycology.

[18]  J. Rowinska UPDATE ON FUNGAL PERITONITIS AND ITS TREATMENT , 2009 .

[19]  G. Pier,et al.  Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination , 2008, PLoS pathogens.

[20]  M. Raška,et al.  Candidiasis — Do we need to fight or to tolerate theCandida fungus? , 2008, Folia Microbiologica.

[21]  A. Imhof,et al.  Bile Aspiration for Diagnosis of Candida glabrata Cholecystitis , 2008, Infection.

[22]  D. Sharma,et al.  Effect of Candida infection on outcome in patients with perforation peritonitis. , 2008, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[23]  G. Harding,et al.  Primary and secondary peritonitis: An update , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  J. Sobel,et al.  Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans , 1999, Clinical Microbiology Reviews.

[25]  S. Mitchell,et al.  Disseminated candidiasis secondary to fungal and bacterial peritonitis in a young dog. , 2009, Journal of veterinary emergency and critical care.

[26]  J. Lopez-Ribot,et al.  Our Current Understanding of Fungal Biofilms , 2009, Critical reviews in microbiology.

[27]  C. Hennequin,et al.  Candida as a risk factor for mortality in peritonitis* , 2006, Critical care medicine.

[28]  J. Vandenbroucke,et al.  Salmonella bacteremia , 1974, Infection.